Weight loss goals: Larger targets may require a longer treatment phase
Estos frmacos incluyen semaglutida (Ozempic, Wegovy), dulaglutida (Trulicity), liraglutida (Victoza, Saxenda) y tirzepatida (Mounjaro, Zepbound), aunque tirzepatida es tcnicamente un agonista dual que acta sobre los receptores GIP y GLP-1
Efficacy and safety of semaglutide 2.4 mg once-weekly in adults with overweight or obesity and type 2 diabetes (STEP 2)
IBRO Neurosci Rep 17:493502
When evaluating adipose tissue in WT and 3-KO mice, researchers found that neither treatment significantly affected white adipose tissue mass in either genotype
Semaglutide, via large studies like SUSTAIN-6, shows it significantly reduces the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death in adults with type 2 diabetes and cardiovascular disease